MBX Biosciences, Inc.
MBX
$8.70
$0.070.81%
| Weiss Ratings | MBX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | D- | |||
| Rating Factors | MBX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Very Weak | |||
| Efficiency Index | Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | MBX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -- | |||
| Price History | MBX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -22.67% | |||
| 30-Day Total Return | -25.26% | |||
| 60-Day Total Return | -54.07% | |||
| 90-Day Total Return | -62.01% | |||
| Year to Date Total Return | -52.33% | |||
| 1-Year Total Return | -- | |||
| 2-Year Total Return | -- | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -68.62% | |||
| 52-Week Low % Change | 1.05% | |||
| Price | MBX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $27.50 | |||
| 52-Week Low Price | $8.54 | |||
| 52-Week Low Price (Date) | Mar 13, 2025 | |||
| 52-Week High Price (Date) | Nov 06, 2024 | |||
| Valuation | MBX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 288.39M | |||
| Enterprise Value | 11.54M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -4.69 | |||
| Earnings Per Share Growth | -55.84% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | 1.06 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $8.70 | |||
| Enterprise Value/EBITDA (TTM) | -0.23 | |||
| Enterprise Value/EBIT | -0.23 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | MBX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 6.52M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | MBX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | (317) 659-0200 | |||
| Address | 11711 N. Meridian Street Carmel, IN 46032 | |||
| Website | mbxbio.com | |||
| Country | United States | |||
| Year Founded | 2018 | |||
| Profitability | MBX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | MBX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -- | |||
| Return on Equity | -- | |||
| Income Statement | MBX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -- | |||
| EBIT (TTM) | -- | |||
| Net Income (TTM) | -- | |||
| Net Income Avl. to Common (TTM) | -- | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | -78.53% | |||
| EPS Diluted (TTM) | -- | |||
| EPS Diluted Growth (Q YOY) | 70.37% | |||
| Balance Sheet | MBX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 277.06M | |||
| Cash Per Share (Q) | $42.52 | |||
| Total Current Assets (Q) | 281.17M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 271.37M | |||
| Current Ratio (Q) | 25.748 | |||
| Book Value Per Share (Q) | $8.13 | |||
| Total Assets (Q) | 282.40M | |||
| Total Current Liabilities (Q) | 10.92M | |||
| Total Debt (Q) | 210.00K | |||
| Total Liabilities (Q) | 11.03M | |||
| Total Common Equity (Q) | 271.37M | |||
| Cash Flow | MBX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | -- | |||
| Net Change in Cash (TTM) | -- | |||
| Levered Free Cash Flow (TTM) | -- | |||
| Cash from Operations (TTM) | -- | |||
